Actively Recruiting
Registry Study of CADASIL and Related Conditions Tracking Clinical Features and Genetic Factors
Led by Bin Cai · Updated on 2023-09-28
1000
Participants Needed
1
Research Sites
521 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a prospective multicenter observational study to understand the clinical spectrum and natural progression of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy CADASIL and related disorders. The study aims to assess the clinical, genetic, and epigenetic characteristics of patients with CADASIL to help improve clinical management of the condition. Participants include CADASIL patients confirmed by genetic test or skin biopsy, asymptomatic carriers of the NOTCH3 mutation, relatives of affected individuals, and unrelated healthy controls. There are no drug or treatment interventions as this is an observational study focused on gathering data over time. Participants will be followed from enrollment until death or up to 20 years, during which researchers will collect clinical information, genetic data, and imaging results. The primary outcome is overall outcomes in CADASIL patients over this period, while secondary outcomes include correlations between genetic findings and clinical features. Assessments will be conducted periodically as part of routine clinical evaluations.
CONDITIONS
Brief Title
CADASIL Registry Study
Research Team
L
Lin Yi, PhD
C
Cai Bin, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here